NSTG Stock Overview
NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
NewNotes are coming soon
NanoString Technologies, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$12.57 |
| 52 Week High | US$41.00 |
| 52 Week Low | US$4.37 |
| Beta | 1.54 |
| 1 Month Change | 55.76% |
| 3 Month Change | 30.67% |
| 1 Year Change | -63.87% |
| 3 Year Change | -57.78% |
| 5 Year Change | 87.05% |
| Change since IPO | 55.96% |
Recent News & Updates
Recent updates
Is It Too Late To Consider Buying NanoString Technologies, Inc. (NASDAQ:NSTG)?
Oct 27
NanoString, Visiopharm team up to develop workflows for spatial biology solutions
Oct 13NanoString Technologies (NASDAQ:NSTG) Has Debt But No Earnings; Should You Worry?
Oct 05An Intrinsic Calculation For NanoString Technologies, Inc. (NASDAQ:NSTG) Suggests It's 35% Undervalued
Aug 08When Should You Buy NanoString Technologies, Inc. (NASDAQ:NSTG)?
Jun 27Is NanoString Technologies (NASDAQ:NSTG) Using Debt In A Risky Way?
May 06Does NanoString Technologies (NASDAQ:NSTG) Have A Healthy Balance Sheet?
Jan 25Is NanoString Technologies (NASDAQ:NSTG) Weighed On By Its Debt Load?
Oct 10NanoString forms alliance to optimize cell therapies in cancer
Jun 15It's Unlikely That NanoString Technologies, Inc.'s (NASDAQ:NSTG) CEO Will See A Huge Pay Rise This Year
Jun 10NanoString’s DSP platform used to create dataset revealing insights into COVID-19
May 04Does NanoString Technologies (NASDAQ:NSTG) Have A Healthy Balance Sheet?
Apr 02If You Had Bought NanoString Technologies (NASDAQ:NSTG) Stock Three Years Ago, You Could Pocket A 964% Gain Today
Feb 26NanoString expects Q4 revenue of $35.7M above guidance
Jan 11How Much Are NanoString Technologies, Inc. (NASDAQ:NSTG) Insiders Taking Off The Table?
Jan 04Nanostring: Strong Life Science Tools Play But Trading At A Premium
Nov 30NanoString EPS beats by $0.10, beats on revenue
Nov 09Shareholder Returns
| NSTG | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | 16.6% | 2.7% | 2.9% |
| 1Y | -63.9% | -10.4% | -8.5% |
Return vs Industry: NSTG underperformed the US Life Sciences industry which returned -12% over the past year.
Return vs Market: NSTG underperformed the US Market which returned -9.1% over the past year.
Price Volatility
| NSTG volatility | |
|---|---|
| NSTG Average Weekly Movement | 18.2% |
| Life Sciences Industry Average Movement | 11.7% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in US Market | 17.6% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: NSTG is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 18% a week.
Volatility Over Time: NSTG's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 766 | Brad Gray | https://www.nanostring.com |
NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files.
NanoString Technologies, Inc. Fundamentals Summary
| NSTG fundamental statistics | |
|---|---|
| Market Cap | US$586.35m |
| Earnings (TTM) | -US$144.69m |
| Revenue (TTM) | US$135.30m |
4.3x
P/S Ratio-4.1x
P/E RatioIs NSTG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NSTG income statement (TTM) | |
|---|---|
| Revenue | US$135.30m |
| Cost of Revenue | US$64.40m |
| Gross Profit | US$70.90m |
| Other Expenses | US$215.59m |
| Earnings | -US$144.69m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -3.10 |
| Gross Margin | 52.40% |
| Net Profit Margin | -106.94% |
| Debt/Equity Ratio | 272.8% |
How did NSTG perform over the long term?
See historical performance and comparison